Cv1 - A Cost-Effectiveness Analysis of Muliti-Gene Pharmacogenetic Testing in Acute Coronary Syndrome Patients Following Percutaneous Coronary Intervention
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.032
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV